Browsing by Yonsei Author : Chung, Hyun Cheol

Name:
정현철 [Chung, Hyun Cheol] http://orcid.org/0000-0002-0920-9471
Department :
College of Medicine - Dept. of Internal Medicine
Y-HRN :
(Yonsei Health Research Network)

Results 1-50 of 266.

This table browses all dspace content
Issue DateTitleYonsei Author(s)
2018Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma. 김경식, 김성훈, 김은경, 김효송, 노성훈, 라선영, 서진석, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁
2018Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study정현철
2018Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012정현철
2018Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial김지형, 김형일, 김효송, 노성훈, 라선영, 박형순, 백송이, 범승훈, 손태일, 임준석, 정민규, 정재호, 정현철, 최은아, 허수진, 형우진
2018MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.김한상, 김현기, 라선영, 정현철
2018Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials.손주혁, 정현철
2018Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer김태수, 라선영, 박규현, 정민규, 정현철
2018Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 정현철
2018Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor김태수, 라선영, 정현철, 정희철
2018Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer정현철, 조재용
2018A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy김승섭, 김효송, 남정모, 라선영, 박경수, 정민규, 정재호, 정현철, 채동우
2018Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer 라선영, 정현철
2018Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial김효송, 라선영, 정민규, 정현철
2018The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status김효송, 라선영, 범승훈, 윤미진, 이충근, 정민규, 정현철, 조응혁
2017ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition김태수, 라선영, 안중배, 정현철, 정희철
2017Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study정현철
2017Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer김건민, 김승일, 박세호, 박형석, 박형순, 백순명, 손주혁, 정현철
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer 금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박규현, 박준철, 배수진, 백순명, 범승훈, 손태일, 신성관, 이상길, 이용찬, 이은영, 이한나, 임준석, 정민규, 정재호, 정현철, 최윤영, 형우진
2017Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study정현철
2017HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib. 정현철
2017Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer 강석민, 김지형, 김효송, 라선영, 박형순, 범승훈, 심지영, 이충근, 정민규, 정현철, 허수진, 홍그루
2017A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer 정현철
2017Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer 김남규, 정현철, 한윤대
2017A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors김건민, 라선영, 신상준, 안중배, 정현철
2017PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer 김주훈, 김태수, 라선영, 박형순, 이충근, 정현철, 허수진
2017Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial정현철, 조재용
2017Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab 김승섭, 김현기, 김효송, 라선영, 박소희, 이충근, 임준석, 정민규, 정현철, 허수진
2017Prevalence and prognostic implications of psychological distress in patients with gastric cancer 김건민, 김경란, 김혜련, 노성훈, 라선영, 송수경, 정현철
2017Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia 김지현, 김현기, 노성훈, 라선영, 박소희, 안중배, 전홍재, 정현철, 정희철, 형우진
2017A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors라선영, 정현철
2017Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines김태수, 라선영, 정현철, 정희철
2017Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer 김태수, 노재경, 라선영, 박규현, 신상준, 안중배, 정현철, 정희철
2017Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline정현철
2016A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma 권우선, 김효송, 라선영, 정현철, 허수진
2016Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.정현철
2016Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer. 정현철
2016Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites 김태수, 김효송, 라선영, 박규현, 박준용, 정현철
2016Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial정현철
2016Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma김경식, 김성훈, 김효송, 노성훈, 라선영, 서진석, 신규호, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁
2016Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박준철, 범승훈, 손태일, 신상준, 신성관, 이상길, 이용찬, 임준석, 정민규, 정재호, 정현수, 정현철, 최윤영, 형우진
2016High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer김남규, 라선영, 신상준, 안중배, 이강영, 정현철, 정희철
2016Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus 김상우, 김소라, 김현기, 김혜련, 김효송, 박형순, 양인석, 이민구, 임선민, 정현철, 조병철
2016Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy김형일, 김효송, 노성훈, 라선영, 안지영, 이충근, 정민규, 정용휴, 정인경, 정재호, 정현철, 허수진, 형우진
2016Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.김현기, 김형일, 김효송, 노성훈, 라선영, 윤미진, 정민규, 정재호, 정현철, 조응혁, 형우진
2016Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial정현철
2015Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer 김정민, 라선영, 안중배, 이강영, 이명은, 이충근, 정현철
2015Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence? 금기창, 김승일, 김용배, 박병우, 서창옥, 손주혁, 이정심, 장지석, 정현철
2015The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer김혜련, 노성훈, 라선영, 전홍재, 정현철, 허수진
2015PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer김효송, 라선영, 장향란, 정민규, 정현철
2015Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer김형일, 김효송, 노성훈, 라선영, 박형순, 정민규, 정재호, 정현철, 형우진

Browse